MINNEAPOLIS, May 31, 2016 (GLOBE NEWSWIRE) -- Skyline Medical Inc.(NASDAQ:SKLN) (Skyline or the Company), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces the engagement of Dawson James Securities, Inc. in an exclusive financial advisory agreement. Under this new agreement, Dawson James is charged with advising on and implementing a financing strategy, identifying acquisition candidates including complementary products and companies and providing advisory services.
We have worked successfully with the equity capital markets team at Dawson James in recent months and are excited to be moving forward under this new agreement as we seek to fund and execute our business plan, said Dr. Carl Schwartz
, interim chief executive officer of Skyline Medical. The STREAMWAY System offers healthcare practitioners a state-of-the-art method for medical fluid disposal, and virtually eliminates contact with medical waste in the procedure room, providing lower costs and improved safety when compared with canister systems. We look forward to strengthening our capital structure and securing additional funds to invest in sales and marketing, and to pursuing acquisitions that are synergistic with our commercial efforts.
About Dawson James Securities, Inc.
Dawson James Securities specializes in capital raising for small and microcap public and private growth companies primarily in the Life Science/Health Care, Technology and Consumer sectors and is a full service investment banking firm with research, institutional and retail sales, as well as execution trading and corporate services. Headquartered in Boca Raton, Fla., Dawson James is privately held with offices in New York, California, Maryland and New Jersey. For additional information, please visit www.dawsonjames.com.
About the STREAMWAY System
Skyline Medicals revolutionary, FDA-cleared STREAMWAY System is the first true direct-to-drain fluid disposal system designed specifically for medical applications, such as radiology, endoscopy, urology and cystoscopy procedures. It connects directly to a facilitys plumbing system to automate the collection, measurement and disposal of waste fluids, and minimizes human intervention for better safety while improving compliance with Occupational Safety and Health Association (OSHA) and other regulatory agency safety guidelines. It also provides unlimited capacity for increased efficiency in the operating room, which leads to greater profitability. The STREAMWAY eliminates canisters to reduce overhead costs and provides greater environmental stewardship by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the US
About Skyline Medical Inc.
Skyline Medical Inc. produces a fully automated, patented, FDA-cleared, waste fluid disposal system that virtually eliminates staff exposure to blood, irrigation fluid and other potentially infectious fluids found in the healthcare environment. Antiquated manual fluid handling methods -- which require hand carrying and emptying filled fluid canisters -- present an exposure risk and potential liability. Skyline Medicals STREAMWAY System fully automates the collection, measurement and disposal of waste fluids and is designed to: 1) reduce overhead costs to hospitals and surgical centers, 2) improve compliance with OSHA and other regulatory agency safety guidelines, 3) improve efficiency in the operating room, and radiology and endoscopy departments -- leading to greater profitability, and 4) provide greater environmental stewardship by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United States. For additional information, please visit www.skylinemedical.com.
Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the Companys business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, current negative operating cash flows and a need for additional funding to finance our operating plan; the terms of any further financing, which may be highly dilutive and may include onerous terms; unexpected costs and operating deficits, and lower than expected sales and revenues; uncertain willingness and ability of customers to adopt new technologies and other factors that may affect further market acceptance, if our product is not accepted by our potential customers, it is unlikely that we will ever become profitable, adverse economic conditions; adverse results of any legal proceedings; the volatility of our operating results and financial condition; inability to attract or retain qualified senior management personnel, including sales and marketing personnel; our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the Companys ability to implement its long range business plan for various applications of its technology; the Companys ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Companys technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Companys reports filed with the Securities and Exchange Commission, which are available for review at www.sec.gov. This is not a solicitation to buy or sell securities and does not purport to be an analysis of the Companys financial position. See the Companys most recent Annual Report on Form 10-K, and subsequent reports and other filings at www.sec.gov.
Source: Skyline Medical Inc.